Alcolase raises EUR 1.5M seed round
The funding will support efficacy trials, regulatory dialogue with Singapore Food Agency, and market entry in Singapore and South Korea.
See the latest news and media coverage for Alcolase. We track all announcements, press releases, and industry mentions in real time, all in one place.
Gastric alcohol-degrading enzyme system
alcolase.comLast updated
In short: Alcolase secured €1.5M in seed funding and formed strategic partnerships to expand its enzyme technology into the East Asian market.
The funding will support efficacy trials, regulatory dialogue with Singapore Food Agency, and market entry in Singapore and South Korea.
Henrik brings extensive scientific experience and will lead Alcolase's product development towards market readiness. He is excited to expand research and collaborations.
The position is based in Copenhagen and focuses on improving lives of those with alcohol intolerance.
They value their partnerships and local network while addressing alcohol intolerance prevalent in South Korea. Their schedule includes meetings and conferences in Seoul and beyond.
The startup is developing a stomach-based enzyme solution aimed at helping millions of people with ALDH2 deficiency reduce the harmful effects of alcohol consumption while...
Non-preservation Pharmaceuticals announced on the 1st that it has signed a memorandum of understanding (MOU) with Danish bio startup Alcolase ApS to promote the alcohol decomposition product business and is exploring entry into the health functional food market.
While Alcolase is aming to commercialize its enzyme system globally, its strategic focus lies in East Asia -- home to an estimated 500 million alcohol-intolerant...
MEET OUR Resident Alcolase On a mission to make drinking alcohol a healthier experience for everyone. Consuming alcohol is a...
Track Alcolase and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.